Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rotonya M Carr

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|November 18, 2021
A new perspective on NAFLD: Focusing on lipid dropletsEleonora Scorletti, Rotonya M Carr
Current Atherosclerosis Reports|February 19, 2015
FXR agonists as therapeutic agents for non-alcoholic fatty liver diseaseRotonya M Carr, Andrea E Reid
Experimental Cell Research|October 31, 2015
Pathophysiology of lipid droplet proteins in liver diseasesRotonya M Carr, Rexford S Ahima
Journal of Lipid Research|April 27, 2019
Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemiaRotonya M Carr, Nicholas O Davidson
Gastroenterology Clinics of North America|November 14, 2016
Nonalcoholic Fatty Liver Disease: Pathophysiology and ManagementRotonya M Carr, Amanke Oranu, Vandana Khungar
The New England Journal of Medicine|July 24, 2024
Hepatologist Consultation in Low-Risk MASLDAbigail Schubach, Rotonya M Carr, Manal F Abdelmalek
Cellular and Molecular Gastroenterology and Hepatology|October 9, 2018
Micronutrients in Nonalcoholic Fatty Liver Disease PathogenesisOctavia Pickett-Blakely, Kimberly Young, Rotonya M Carr
The Journal of Clinical Investigation|April 1, 2025
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovationsBernd Schnabl, Christopher J Damman, Rotonya M Carr
Clinical Liver Disease|September 6, 2021
Transition of Care Model for Pediatric Patients With Nonalcoholic Fatty Liver DiseaseRobert Mitrani, Taisa Kohut, Jennifer Panganiban, et al.
Gastroenterology|August 25, 2015
Reducing colorectal cancer risk among African AmericansSonia S Kupfer, Rotonya M Carr, John M Carethers
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|November 18, 2021
A new perspective on NAFLD: Focusing on lipid dropletsEleonora Scorletti, Rotonya M Carr
Current Atherosclerosis Reports|February 19, 2015
FXR agonists as therapeutic agents for non-alcoholic fatty liver diseaseRotonya M Carr, Andrea E Reid
Experimental Cell Research|October 31, 2015
Pathophysiology of lipid droplet proteins in liver diseasesRotonya M Carr, Rexford S Ahima
Journal of Lipid Research|April 27, 2019
Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemiaRotonya M Carr, Nicholas O Davidson
Gastroenterology Clinics of North America|November 14, 2016
Nonalcoholic Fatty Liver Disease: Pathophysiology and ManagementRotonya M Carr, Amanke Oranu, Vandana Khungar
The New England Journal of Medicine|July 24, 2024
Hepatologist Consultation in Low-Risk MASLDAbigail Schubach, Rotonya M Carr, Manal F Abdelmalek
Cellular and Molecular Gastroenterology and Hepatology|October 9, 2018
Micronutrients in Nonalcoholic Fatty Liver Disease PathogenesisOctavia Pickett-Blakely, Kimberly Young, Rotonya M Carr
The Journal of Clinical Investigation|April 1, 2025
Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovationsBernd Schnabl, Christopher J Damman, Rotonya M Carr
Clinical Liver Disease|September 6, 2021
Transition of Care Model for Pediatric Patients With Nonalcoholic Fatty Liver DiseaseRobert Mitrani, Taisa Kohut, Jennifer Panganiban, et al.
Gastroenterology|August 25, 2015
Reducing colorectal cancer risk among African AmericansSonia S Kupfer, Rotonya M Carr, John M Carethers
Pageof 7